Skip to main content
. 2014 Jan 13;2014(1):CD003559. doi: 10.1002/14651858.CD003559.pub4

Comparison 4. Subcutaneous omalizumab versus placebo (without inhaled corticosteroids).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 FEV1 (litres) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Mild asthma 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Moderate asthma 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Severe asthma 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 FEV1 (% predicted) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
3 Change in PC20 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected